Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 178, Issue 1-2, 2006, Pages 30-39

  Kirwin, Stefanie J ^a   Dowdell, Kenichi C ^a   Hindinger, Claudia ^a   Feng, Ni ^a   Bergmann, Cornelia C ^a   Hinton, David R ^a   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Autoimmunity; EAE MS; Th1 Th2 cells

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DEMYELINATION; ENVIRONMENT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; INFLAMMATION; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEMOCYANIN; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MALE; MICE; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; TH1 CELLS; TH2 CELLS;

EID: 33748112274     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.05.015     Document Type: Article

References (54)

1. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195 (2002) 603-616
2. Bebo Jr. B.F., et al. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J. Neurosci. Res. 52 (1998) 420-426
3. Begolka W.S., et al. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161 (1998) 4437-4446
4. Bergmann C.C., et al. Perforin-mediated effector function within the central nervous system requires IFN-γ-mediated MHC up-regulation. J. Immunol. 170 (2003) 3204-3213
5. Bettelli E., et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161 (1998) 3299-3306
6. Bongioanni M.R., et al. Systemic high-dose recombinant-α-2a-interferon therapy modulates lymphokine production in multiple sclerosis. J. Neurol. Sci. 143 (1996) 91-99
7. Brown A.M., and McFarlin D.E. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 45 (1981) 278-284
8. Cannella B., et al. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45 (1996) 735-746
9. Chitnis T., et al. Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. J. Immunol. 172 (2004) 4260-4265
10. Coffman R.L., et al. The stability and reversibility of Th1 and Th2 populations. Curr. Top. Microbiol. Immunol. 238 (1999) 1-12
11. Corbin G.A., and Harty J.T. T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen. J. Immunol. 174 (2005) 718-726
12. Croxford J.L., et al. Different therapeutic outcomes in experimental allergic encephalomyelitis dependant upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system. J. Immunol. 166 (2001) 4124-4130
13. Cua D.J., et al. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155 (1995) 4052-4059
14. Cua D.J., et al. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J. Immunol. 157 (1996) 2830-2836
15. Cua D.J., et al. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189 (1999) 1005-1010
16. Cua D.J., et al. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166 (2001) 602-608
17. Dhib-Jalbut S. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Pharmacol. Ther. 98 (2003) 245-255
18. Duda P.W., et al. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 105 (2000) 967-976
19. Falcone M., and Bloom B.R. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185 (1997) 901-907
20. Falcone M., et al. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol. 160 (1998) 4822-4830
21. Fillatreau S., et al. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3 (2002) 944-950
22. Greter M., et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005) 328-334
23. Groux H., and Cottrez F. The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 20 (2003) 281-285
24. Harling-Berg C.J., et al. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J. Neuroimmunol. 101 (1999) 111-127
25. Hickey W. Basic principles of immunological surveillance of the normal central nervous system. Glia 36 (2001) 118-124
26. IFNB Multiple Sclerosis Study Group and University of British Columbia MS/MRI Analysis Group. Interferon β-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45 (1995) 1277-1285
27. Kennedy M., et al. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149 (1992) 2496-2505
28. Khoruts A., et al. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 155 (1995) 5011-5017
29. Kim C., and Tse H.Y. Adoptive transfer of murine experimental autoimmune encephalomyelitis in SJL. Thy-1 congenic mouse strains. J. Neuroimmunol. 46 (1993) 129-136
30. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16 (1995) 34-38
31. Matejuk A., et al. Opposing roles for TGF-β1 and TGF-β3 isoforms in experimental autoimmune encephalomyelitis. Cytokine 25 (2004) 45-51
32. Mathisen P.M., et al. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186 (1997) 159-164
33. Matsushima G.K., and Stohlman S.A. Maturation of the delayed-type hypersensitivity response in SJL mice: absence of effector cell induction. Eur. J. Immunol. 18 (1988) 1411-1416
34. + regulatory cells within the central nervous system. J. Immunol. 175 (2005) 3025-3032
35. McMahon E.J., et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11 (2005) 335-339
36. Mirowska D., et al. Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-β-1a treatment in multiple sclerosis patients. J. Neurol. 250 (2003) 1229-1236
37. Moore K.W., et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
38. Nagelkerken L., et al. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 9 (1997) 1243-1251
39. Neuhaus O., et al. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. PNAS 97 (2000) 7452-7457
40. - T lymphocytes. J. Immunol. 127 (1981) 1420-1423
41. Ramírez F., and Mason D. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Eur. J. Immunol. 30 (2000) 747-758
42. Rott O., et al. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24 (1994) 1434-1440
43. Rudick R.A., et al. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 40 (1996) 618-627
44. Sakaguchi S., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
45. Selmaj K.W., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23 (1988) 339-346
46. Shaw M.K., et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185 (1997) 1711-1714
47. Stohlman S.A., et al. The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur. J. Immunol. 15 (1985) 913-916
48. Stohlman S.A., et al. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. J. Immunol. 163 (1999) 6338-6344
49. Targoni O.S., et al. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 166 (2001) 4757-4764
50. van der Veen R.C., and Stohlman S.A. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48 (1993) 213-220
51. Voskuhl R.R., et al. Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis. Ann. Neurol. 39 (1996) 724-733
52. Wållberg M., et al. Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA/1 mice from experimental autoimmune encephalomyelitis. Eur. J. Immunol. 33 (2003) 1539-1547
53. Wildbaum G., et al. Plasmid DNA encoding IFN-γ-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 168 (2002) 5885-5892
54. Zamvil S.S., and Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8 (1990) 579-621